(US) Select Premarket Movers
Upside: -ABSI +25% (reports positive interim Phase 1 data for ABS-201 in androgenetic alopecia; prices 13.5M share common stock offering at $7.41/shr) -WEN +22% (meme trading momentum) -RUN +20% (agrees with Renew Home, Tesla to deliver more than 16 GW flexible energy capacity to hyperscalers, utilities) -FCEL +17% (announces up to 380 MW clean baseload on-site power agreement with Fit Energy) -MODD +8.9% (pivot tubeless insulin patch pump commercially available in the U.S. after FDA 510(k) clearance in April) -MU +4.9% (strength ahead of reporting earnings post-close) -CALC +4.8% (enters private placement for up to $49M to advance pulmonary hypertension program; may continue dosing Auxora in Phase 2 KOURAGE trial after FDA review) -TOST +4.3% (to replace BLD in the S&P MidCap 400 Index, effective Jul 1st) -TWLO +3.9% (rated Buy at Goldman) -KBH +3.5% (earnings, guidance) -SNDK +3.5% (sector strength ahead of MU earnings) -BB +3.0% (Stifel Nicolaus Initiates BB with Buy, price targe...
Upside: -ABSI +25% (reports positive interim Phase 1 data for ABS-201 in androgenetic alopecia; prices 13.5M share common stock offering at $7.41/shr) -WEN +22% (meme trading momentum) -RUN +20% (agrees with Renew Home, Tesla to deliver more than 16 GW flexible energy capacity to hyperscalers, utilities) -FCEL +17% (announces up to 380 MW clean baseload on-site power agreement with Fit Energy) -MODD +8.9% (pivot tubeless insulin patch pump commercially available in the U.S. after FDA 510(k) clearance in April) -MU +4.9% (strength ahead of reporting earnings post-close) -CALC +4.8% (enters private placement for up to $49M to advance pulmonary hypertension program; may continue dosing Auxora in Phase 2 KOURAGE trial after FDA review) -TOST +4.3% (to replace BLD in the S&P MidCap 400 Index, effective Jul 1st) -TWLO +3.9% (rated Buy at Goldman) -KBH +3.5% (earnings, guidance) -SNDK +3.5% (sector strength ahead of MU earnings) -BB +3.0% (Stifel Nicolaus Initiates BB with Buy, price target: $12) -TTWO +2.5% (prices GTA VI at $79.99 with Ultimate Edition at $99.99; confirms pre-orders begin June 25th) -BILI +2.3% (authorizes $300M share repurchase program) Downside: -TOYO -24% (prices $50M registered direct offering at $11.00/shr and warrant) -HTZ -19% (guidance; files automatic shelf registration for $100M common stock offering and plans $300M exchangeable senior first-lien secured PIK notes due 2030) -CBRS -7.3% (earnings, guidance) -FDX -7.2% (earnings, guidance)